Clinical Trial Update: Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluated repeated subarachnoid administrations of human umbilical cord mesenchymal stem cells (hUC-MSCs) for spinal cord injur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• hUC-MSCs (human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Limin Rong | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-30